Ebola's future development footprint

    Though hopeful for a vaccine, experts believe global pandemics like Ebola are set to become regular fixtures in tomorrow's development landscape. Shifts in funding strategies, how the commercial pharmaceutical industry works and even how humanitarian organizations are structured will surely follow.

    About the author

    • Molly Anders

      Molly Anders is a former U.K. correspondent for Devex. Based in London, she reports on development finance trends with a focus on British and European institutions. She is especially interested in evidence-based development and women’s economic empowerment, as well as innovative financing for the protection of migrants and refugees. Molly is a former Fulbright Scholar and studied Arabic in Syria, Jordan, Egypt and Morocco.